CN113057244A - Preparation process of tablet candy with immunoregulation effect - Google Patents
Preparation process of tablet candy with immunoregulation effect Download PDFInfo
- Publication number
- CN113057244A CN113057244A CN202110471927.3A CN202110471927A CN113057244A CN 113057244 A CN113057244 A CN 113057244A CN 202110471927 A CN202110471927 A CN 202110471927A CN 113057244 A CN113057244 A CN 113057244A
- Authority
- CN
- China
- Prior art keywords
- parts
- raw materials
- tabletting
- leaching
- enzymolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 230000000694 effects Effects 0.000 title claims abstract description 18
- 230000007365 immunoregulation Effects 0.000 title claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 53
- 238000002386 leaching Methods 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims abstract description 40
- 239000007788 liquid Substances 0.000 claims abstract description 27
- 108090000790 Enzymes Proteins 0.000 claims abstract description 24
- 102000004190 Enzymes Human genes 0.000 claims abstract description 24
- 239000006228 supernatant Substances 0.000 claims abstract description 22
- 238000000926 separation method Methods 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 12
- 241000234435 Lilium Species 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 12
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 12
- 244000248825 Peltandra virginica Species 0.000 claims abstract description 12
- 235000001188 Peltandra virginica Nutrition 0.000 claims abstract description 12
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 12
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 12
- 235000008434 ginseng Nutrition 0.000 claims abstract description 12
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 11
- 239000003765 sweetening agent Substances 0.000 claims abstract description 11
- 230000000415 inactivating effect Effects 0.000 claims abstract description 10
- 238000010298 pulverizing process Methods 0.000 claims abstract description 10
- 238000007873 sieving Methods 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 6
- 235000002723 Dioscorea alata Nutrition 0.000 claims abstract description 5
- 235000005362 Dioscorea floribunda Nutrition 0.000 claims abstract description 5
- 235000004868 Dioscorea macrostachya Nutrition 0.000 claims abstract description 5
- 235000005361 Dioscorea nummularia Nutrition 0.000 claims abstract description 5
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 claims abstract description 5
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 5
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 claims abstract description 3
- 235000007056 Dioscorea composita Nutrition 0.000 claims abstract description 3
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 claims abstract description 3
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 claims abstract description 3
- 230000002378 acidificating effect Effects 0.000 claims description 22
- 229940088598 enzyme Drugs 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 18
- 108010059892 Cellulase Proteins 0.000 claims description 13
- 108010059820 Polygalacturonase Proteins 0.000 claims description 13
- 229940106157 cellulase Drugs 0.000 claims description 13
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 11
- 240000002045 Guettarda speciosa Species 0.000 claims description 11
- 238000000605 extraction Methods 0.000 claims description 11
- 229920002261 Corn starch Polymers 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 239000008120 corn starch Substances 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 238000005469 granulation Methods 0.000 claims description 9
- 230000003179 granulation Effects 0.000 claims description 9
- 230000002519 immonomodulatory effect Effects 0.000 claims description 9
- 235000019359 magnesium stearate Nutrition 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 9
- 229960004793 sucrose Drugs 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims description 8
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 2
- 238000005119 centrifugation Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims 2
- 229940126589 solid medicine Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 8
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 238000001556 precipitation Methods 0.000 abstract description 5
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000012467 final product Substances 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 description 12
- 239000002158 endotoxin Substances 0.000 description 10
- 229920006008 lipopolysaccharide Polymers 0.000 description 10
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 9
- 150000004676 glycans Chemical class 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 5
- 239000012980 RPMI-1640 medium Substances 0.000 description 5
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 5
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 229920001503 Glucan Polymers 0.000 description 4
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920001612 Hydroxyethyl starch Polymers 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 229940050526 hydroxyethylstarch Drugs 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 108010011485 Aspartame Proteins 0.000 description 2
- 108010047620 Phytohemagglutinins Proteins 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 229960002743 glutamine Drugs 0.000 description 2
- 238000013394 immunophenotyping Methods 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 230000001885 phytohemagglutinin Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000836983 Homo sapiens Secretoglobin family 1D member 1 Proteins 0.000 description 1
- 102100028659 Secretoglobin family 1D member 1 Human genes 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002246 beta-d-glucopyranose Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 230000006433 tumor necrosis factor production Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the technical field of food processing, and particularly relates to a preparation process of a tablet candy with an immunoregulation effect. The preparation process of the pressed candy comprises the following steps: s1: pulverizing the raw materials, and sieving; the raw materials are as follows: ginseng, angelica, yam, lily, jujube and tuckahoe; s2: adding compound enzyme into the raw material sieved in the S1 for enzymolysis, and inactivating enzyme; s3: carrying out solid-liquid separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution; s4: and (4) concentrating the leaching liquor in the S3 and the supernatant obtained by solid-liquid separation into thick paste, adding a sweetening agent and auxiliary materials, uniformly mixing, granulating and tabletting to obtain the tablet candy. The invention has the beneficial effects that: (1) extracting active ingredients in the raw materials by adopting an enzymolysis mode, and fully dissolving out the active ingredients to ensure that the final product has higher active ingredient content; (2) compared with the alcohol precipitation method, the method of the invention does not consume organic solvent, is environment-friendly and has mild preparation conditions.
Description
Technical Field
The invention belongs to the technical field of food processing, and particularly relates to a preparation process of a tablet candy with an immunoregulation effect.
Background
As for documents having an immunomodulatory effect, the following patent applications are disclosed:
CN112375157A proposes a codonopsis pilosula glucan with immunoregulation effect, which is characterized in that: the codonopsis pilosula glucan is formed by connecting alpha-D-glucopyranose 1 → 4 glycosidic bonds in a main chain and is formed by connecting beta-D-glucopyranose 6 → 1 glycosidic bonds in a branched chain. The method comprises the following steps: (1) extracting codonopsis pilosula polysaccharide, soaking the codonopsis pilosula medicinal material for 30min according to the material-liquid ratio of 1: 10-1: 20, heating and refluxing for extraction for 3 times, wherein each time lasts for 1.5h, and combining three extracting solutions; (2) alcohol precipitation of the codonopsis pilosula polysaccharide, namely, decompressing and concentrating a codonopsis pilosula polysaccharide extracting solution to 1/4-1/3 volume, adopting 60-90% ethanol for precipitation, centrifuging for 15-30 min at 1000-1500 rpm, removing supernatant, washing precipitates for 3 times by using diethyl ether, ethyl acetate, acetone and absolute ethyl alcohol in sequence, and freeze-drying to obtain a codonopsis pilosula polysaccharide sample; (3) and carrying out ultrafiltration separation on the codonopsis pilosula polysaccharide, dissolving the codonopsis pilosula polysaccharide sample by using water, and finally filtering the dissolved codonopsis pilosula polysaccharide sample by using a filter membrane with a molecular weight of 3000 to obtain the codonopsis pilosula glucan with the immunoregulation effect.
The codonopsis pilosula glucan adopts an ultrafiltration method in the preparation process, the ultrafiltration cost is high, an alcohol precipitation method is also adopted in the preparation process, and the method consumes a large amount of organic solvents and is not environment-friendly.
Therefore, there is a need for improvement over the above-mentioned methods, and to invent a method for preparing a tabletted confectionery that is mild in preparation conditions and relatively low in cost.
Disclosure of Invention
In order to solve the technical problems, the invention provides a preparation method of the tabletted candy with mild preparation conditions and relatively low cost.
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the raw materials are as follows: ginseng, angelica, yam, lily, jujube and tuckahoe;
s2: adding compound enzyme into the raw material sieved in the S1 for enzymolysis, and inactivating enzyme;
s3: carrying out solid-liquid separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: and (4) concentrating the leaching liquor in the S3 and the supernatant obtained by solid-liquid separation into thick paste, adding a sweetening agent and auxiliary materials, uniformly mixing, granulating and tabletting to obtain the tablet candy.
The weight parts of the raw materials are as follows: 10-15 parts of ginseng, 10-15 parts of angelica, 20-30 parts of Chinese yam, 40-50 parts of lily, 10-15 parts of Chinese date and 10-15 parts of tuckahoe.
Preferably, in S1, the raw material is pulverized and sieved through a 60-mesh sieve.
Preferably, in S2, the complex enzyme is acidic cellulase and acidic pectinase, and the weight ratio of the acidic cellulase to the acidic pectinase is 0.8-1.2: 1.
preferably, in S2, the adding amount of the acidic cellulase and the acidic pectinase is 1-2% of the total weight of the raw materials.
Preferably, when the compound enzyme in the S2 is used for enzymolysis, water is added, and the weight ratio of the raw materials to the water is 1: 7-11; adjusting the pH value to 4.5-5.0, and carrying out enzymolysis for 50-70 min at the temperature of 40-50 ℃.
Preferably, the solid-liquid separation method in S3 is centrifugal separation.
Preferably, in S3, the water decoction and extraction of the solid residue comprises the following steps: adding water with the weight 8-10 times of that of the decoction dregs into the decoction dregs, leaching for 15-30 min in boiling water, and centrifuging for 10-15 min at the rotating speed of 4000-5000 r/min.
Preferably, in S4, the leaching liquor and the supernatant are concentrated to 10-15% of the total volume of the leaching liquor and the supernatant, and leaching paste is obtained;
in S4, the auxiliary materials are as follows: weighing 30-50 parts of corn starch, 5-10 parts of magnesium stearate, 5-10 parts of microcrystalline cellulose, 15-20 parts of dextrin, 20-30 parts of sucrose and 5-10 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 30-40% of the total weight of the raw materials, and during granulation, the raw materials are dried at 80 ℃ until the water content is below 5%;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Preferably, the preparation process of the tabletted candy with the immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 10-15 parts of ginseng, 10-15 parts of angelica, 20-30 parts of Chinese yam, 40-50 parts of lily, 10-15 parts of Chinese date and 10-15 parts of tuckahoe;
s2: adding a compound enzyme consisting of acid cellulase and acid pectinase into the raw material sieved in the S1 for enzymolysis, and inactivating the enzyme for 5-15 min at 95 ℃;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 10-15% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding a sweetening agent and auxiliary materials, uniformly mixing, granulating and tabletting to obtain tabletting candies;
the preparation method of the auxiliary materials comprises the following steps: weighing 30-50 parts of corn starch, 5-10 parts of magnesium stearate, 5-10 parts of microcrystalline cellulose, 15-20 parts of dextrin, 20-30 parts of cane sugar and 5-10 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 30-40% of the total weight of the raw materials, and during granulation, the raw materials are dried at 80 ℃ until the water content is below 5%;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
The invention has the beneficial effects that:
(1) in the invention, the active ingredients in the raw materials are extracted by adopting an enzymolysis mode, so that the active ingredients are fully dissolved out, and the content of the active ingredients in the final product is higher;
(2) compared with the alcohol precipitation method, the method of the invention does not consume organic solvent, is environment-friendly and has mild preparation conditions.
Drawings
FIG. 1 is a flow chart of the process for preparing the tabletted candy according to the present invention.
Detailed Description
The present invention will now be further described with reference to specific embodiments in order to enable those skilled in the art to better understand the present invention.
Example 1
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 12 parts of ginseng, 12 parts of angelica, 25 parts of yam, 45 parts of lily, 13 parts of jujube and 13 parts of tuckahoe;
s2: adding complex enzyme composed of acidic cellulase and acidic pectinase into the sieved raw material in S1 for enzymolysis, and inactivating enzyme at 95 deg.C for 10 min;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 13% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding a sweetening agent xylitol and auxiliary materials, uniformly mixing, granulating and tabletting to obtain tablet candy; the sweetener accounts for 8% of the total weight of the tabletted candy;
the preparation method of the auxiliary materials comprises the following steps: weighing 40 parts of corn starch, 8 parts of magnesium stearate, 8 parts of microcrystalline cellulose, 18 parts of dextrin, 25 parts of sucrose and 8 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 35 percent of the total weight of the raw materials, and are dried at 80 ℃ until the water content is less than 5 percent during granulation;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Example 2
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 12 parts of ginseng, 12 parts of angelica, 23 parts of yam, 43 parts of lily, 12 parts of Chinese date and 12 parts of tuckahoe;
s2: adding complex enzyme composed of acidic cellulase and acidic pectinase into the sieved raw material in S1 for enzymolysis, and inactivating enzyme at 95 deg.C for 7 min;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 13% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding the sweetener stevioside and the auxiliary materials, uniformly mixing, granulating and tabletting to obtain the tablet candy; stevioside accounts for 8% of the total weight of the tabletted candy;
the preparation method of the auxiliary materials comprises the following steps: weighing 38 parts of corn starch, 7 parts of magnesium stearate, 7 parts of microcrystalline cellulose, 17 parts of dextrin, 23 parts of sucrose and 7 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 33 percent of the total weight of the raw materials, and are dried at 80 ℃ until the water content is less than 5 percent during granulation;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Example 3
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 10 parts of ginseng, 10 parts of angelica, 20 parts of Chinese yam, 40 parts of lily, 10 parts of Chinese date and 10 parts of tuckahoe;
s2: adding complex enzyme composed of acidic cellulase and acidic pectinase into the sieved raw material in S1 for enzymolysis, and inactivating enzyme at 95 deg.C for 5 min;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 10% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding the sweetener xylitol and the auxiliary materials, uniformly mixing, granulating and tabletting to obtain the tablet candy; xylitol accounts for 10% of the total weight of the tabletted candy;
the preparation method of the auxiliary materials comprises the following steps: weighing 30 parts of corn starch, 5 parts of magnesium stearate, 5 parts of microcrystalline cellulose, 15 parts of dextrin, 20 parts of sucrose and 5 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 30 percent of the total weight of the raw materials, and are dried at 80 ℃ until the water content is less than 5 percent during granulation;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Example 4
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 15 parts of ginseng, 15 parts of angelica, 30 parts of Chinese yam, 50 parts of lily, 15 parts of Chinese date and 15 parts of tuckahoe;
s2: adding complex enzyme composed of acidic cellulase and acidic pectinase into the sieved raw material in S1 for enzymolysis, and inactivating enzyme at 95 deg.C for 15 min;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 15% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding the sweetening agent aspartame and auxiliary materials, uniformly mixing, granulating and tabletting to obtain tablet candy; aspartame accounts for 9% of the total weight of the tabletted candy;
the preparation method of the auxiliary materials comprises the following steps: weighing 50 parts of corn starch, 10 parts of magnesium stearate, 10 parts of microcrystalline cellulose, 20 parts of dextrin, 30 parts of sucrose and 10 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 40 percent of the total weight of the raw materials, and are dried at 80 ℃ until the water content is less than 5 percent during granulation;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Example 5
A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 10-15 parts of ginseng, 14 parts of angelica, 27 parts of Chinese yam, 47 parts of lily, 14 parts of Chinese date and 14 parts of tuckahoe;
s2: adding complex enzyme composed of acidic cellulase and acidic pectinase into the sieved raw material in S1 for enzymolysis, and inactivating enzyme at 95 deg.C for 12 min;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching solution and the supernatant in the S3 to 14% of the total volume of the leaching solution and the supernatant to obtain leaching paste, adding the sweetening agent disodium glycyrrhizinate and the auxiliary materials, uniformly mixing, granulating and tabletting to obtain tabletting candies; the disodium glycyrrhizinate accounts for 10% of the total weight of the tabletted candy;
the preparation method of the auxiliary materials comprises the following steps: weighing 42 parts of corn starch, 9 parts of magnesium stearate, 9 parts of microcrystalline cellulose, 19 parts of dextrin, 27 parts of sucrose and 9 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 37 percent of the total weight of the raw materials, and are dried at 80 ℃ until the water content is less than 5 percent during granulation;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Example 6
In order to verify the immunomodulatory efficacy of the tabletted confectioneries obtained in the present invention, the inventors carried out the following experiments:
materials: LPS (LPS, from E.coli 055: B5)), lipopolysaccharide, Shanghai Rinshu Biotech Co., Ltd;
PHA: phytohemagglutinin, shanghai ihua corporation, dry powder;
RPMI1640 culture solution: manufactured by Hyclone corporation;
the method comprises the following steps:
6.1 analysis of separation of Peripheral Blood Mononuclear Cells (PBMC) from the tabletted sweetmeat of example 1, the procedure used was as follows:
HES centrifugal separation;
materials: taking 10 parts of peripheral blood; 6% HES (hydroxyethyl starch) commercially available;
diluting heparin anticoagulated whole blood by RPMI1640 according to the proportion of 1:1, performing gradient centrifugation with a Ficoll lymphocyte separation solution with the volume of 2:1, and separating PBMC;
the cell number was adjusted to 2X 10 in RPMI1640 medium containing 1% L-glu-tamine and 10% autologous plasma6Per ml, 2X 10 of 0.1ml per well6The inhibition of TNF-alpha and TGF-beta by the tabletted sweetmeats was examined in 96-well plates with PBMC at ml.
The method for separating the mononuclear cells by adopting an adsorption method comprises the following specific steps: PBMC were adjusted to 10 in RPMI1640 medium without autologous plasma7Adding into culture flask at 37 deg.C with 5% CO2Culturing for 2 hours, absorbing culture supernatant containing non-adherent cells, washing with Hanks liquid for 2 times, adding Trypsin-0.05EDTA, standing at 4 deg.C for 15 minutes, and collecting mononuclear cells.
Pretreatment experiments of tabletted confections with PBMC and monocytes were performed in RPMI1640 medium containing 1% L-glu-tamine, 10% autologous plasma.
1. mu.g/ml LPS (LPS, from E.Coli 055: B5)) and 1. mu.g/ml PHA were used to induce TNF-. alpha.and TGF-. beta.respectively.
PBMC (2X 10 concentration) was added at 100. mu.g/ml per well in 96-well plates6Per ml), 50. mu.g of different concentrations of tabletted candy and 50. mu.l of LPS (1. mu.g/ml), the different concentrations of tabletted candy being: 1ng/ml, 5ng/ml, 10ng/ml, 15ng/ml, 30ng/ml, 50 ng/ml. A positive control group containing 1. mu.g/ml LPS was set for each reaction, a 20ng/ml tabletted candy group, a blank control group without any inducer were also set, and the three groups were incubated in parallel for 24 hours. The tabletted confectioneries were then observed for inhibition of lipopolysaccharide LPS-induced TNF- α.
When observing the inhibition of the tabletting candies on the TGF-beta induced by the phytohemagglutinin PHA, selecting different concentrations of the tabletting candies to be co-cultured with 5 mu g/ml of LPHA, wherein the concentrations of the different concentrations of the tabletting candies are as follows: 1ng/ml, 5ng/ml, 10ng/ml, 15ng/ml and 40 ng/ml; and a positive group and a blank control group were set, and both groups were cultured in parallel for 6 days. The cultured supernatant was collected and the production levels of TNF-. alpha.and TGF-. beta.were measured by ELISA.
2. Immunophenotyping, in which the source of TNF-alpha producing cells is analyzed by using the immunophenotyping of a flow cytometer when the culture of the PBMC pretreatment test is stopped, the difference of the number of the TNF-alpha producing cells and the inhibition of the tabletting candy on the TNF-alpha are compared, and an undyed group and an isotype control dyed group are respectively arranged.
Calculation of TNF-alpha and TGF-beta inhibition:
inhibition rate ═ 1- (tripterygium wilfordii + cleavage source experimental wells)/cleavage source control wells ] x 100%.
The results are as follows:
TABLE 1 ELISA test of the Effect of different concentrations of tabletted sweets on TNF- α production after pretreatment of monocytes
Note: the above 1, 2 and 3 represent the results of the parallel experiments, respectively.
TABLE 2 ELISA test of TGF-beta inhibition of different concentrations of tabletted sweets after pretreatment of monocytes
Note: the above 1, 2 and 3 represent the results of the parallel experiments, respectively.
Through the above experiments, it was confirmed that the tabletted confectionery of the present invention can inhibit the production of TNF-. alpha.and TGF-. beta.by LPS induced PBMCs of healthy humans and is also affected by the dose. This shows that the tabletted sweetmeat of the present invention has an immunomodulating effect and also has a certain anti-inflammatory effect.
Claims (10)
1. A preparation process of a tablet candy with an immunoregulation effect comprises the following steps:
s1: pulverizing the raw materials, and sieving; the raw materials are as follows: ginseng, angelica, yam, lily, jujube and tuckahoe;
s2: adding compound enzyme into the raw material sieved in the S1 for enzymolysis, and inactivating enzyme;
s3: carrying out solid-liquid separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: and (4) concentrating the leaching liquor in the S3 and the supernatant obtained by solid-liquid separation into thick paste, adding a sweetening agent and auxiliary materials, uniformly mixing, granulating and tabletting to obtain the tablet candy.
2. The process for preparing a tabletted candy with an immunomodulatory effect as claimed in claim 1, wherein the raw materials are in parts by weight as follows: 10-15 parts of ginseng, 10-15 parts of angelica, 20-30 parts of Chinese yam, 40-50 parts of lily, 10-15 parts of Chinese date and 10-15 parts of tuckahoe.
3. The process for preparing a tabletted candy with an immunomodulatory effect according to claim 1, wherein in S1 the raw materials are crushed and sieved through a 60 mesh sieve.
4. The preparation process of the tabletted candy with the immunoregulation effect as claimed in claim 1, wherein in S2, the complex enzyme is acidic cellulase and acidic pectinase, and the weight ratio of the acidic cellulase to the acidic pectinase is 0.8-1.2: 1.
5. the process for preparing a tabletted candy with an immunomodulatory effect according to claim 1, wherein the acidic cellulase and acidic pectinase are added in an amount of 1-2% by weight of the total weight of the raw materials in S2.
6. The preparation process of the tabletted candy with the immunoregulation effect as claimed in claim 1, wherein water is added during the enzymolysis of the complex enzyme in S2, and the weight ratio of the raw materials to the water is 1: 7-11; adjusting the pH value to 4.5-5.0, and carrying out enzymolysis for 50-70 min at the temperature of 40-50 ℃.
7. The process for preparing a tabletted candy product with an immunomodulatory effect according to claim 1, wherein the solid-liquid separation in S3 is centrifugation.
8. The preparation process of the tabletted candy with the immunoregulation effect according to claim 1, wherein in S3, the specific steps of taking solid medicine residues and decocting and leaching with water are as follows: adding water with the weight 8-10 times of that of the decoction dregs into the decoction dregs, leaching for 15-30 min in boiling water, and centrifuging for 10-15 min at the rotating speed of 4000-5000 r/min.
9. The process for preparing a tabletted candy with an immunomodulatory effect according to claim 1, wherein in S4, the leaching solution and the supernatant are concentrated to 10-15% of the total volume of the two solutions to obtain a leaching paste;
in S4, the auxiliary materials are as follows: weighing 30-50 parts of corn starch, 5-10 parts of magnesium stearate, 5-10 parts of microcrystalline cellulose, 15-20 parts of dextrin, 20-30 parts of sucrose and 5-10 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 30-40% of the total weight of the raw materials, and during granulation, the raw materials are dried at 80 ℃ until the water content is below 5%;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
10. The process for preparing a tabletted candy product with an immunomodulatory effect according to claim 1, comprising the steps of:
s1: pulverizing the raw materials, and sieving; the weight parts of the raw materials are as follows: 10-15 parts of ginseng, 10-15 parts of angelica, 20-30 parts of Chinese yam, 40-50 parts of lily, 10-15 parts of Chinese date and 10-15 parts of tuckahoe;
s2: adding a compound enzyme consisting of acid cellulase and acid pectinase into the raw material sieved in the S1 for enzymolysis, and inactivating the enzyme for 5-15 min at 95 ℃;
s3: carrying out solid-liquid centrifugal separation on the enzymolysis liquid in the S2, and taking solid dregs to decoct and leach to obtain a leaching solution;
s4: concentrating the leaching liquor and the supernatant liquor in the S3 to 10-15% of the total volume of the leaching liquor and the supernatant liquor to obtain leaching paste, adding a sweetening agent and auxiliary materials, uniformly mixing, granulating and tabletting to obtain tabletting candies;
the preparation method of the auxiliary materials comprises the following steps: weighing 30-50 parts of corn starch, 5-10 parts of magnesium stearate, 5-10 parts of microcrystalline cellulose, 15-20 parts of dextrin, 20-30 parts of cane sugar and 5-10 parts of extraction paste, and uniformly mixing;
the auxiliary materials account for 30-40% of the total weight of the raw materials, and during granulation, the raw materials are dried at 80 ℃ until the water content is below 5%;
during tabletting, the materials are poured into a hopper of a tabletting machine, and tabletting and forming are carried out in the environment with room temperature and relative humidity of less than 70 percent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110471927.3A CN113057244A (en) | 2021-04-29 | 2021-04-29 | Preparation process of tablet candy with immunoregulation effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110471927.3A CN113057244A (en) | 2021-04-29 | 2021-04-29 | Preparation process of tablet candy with immunoregulation effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113057244A true CN113057244A (en) | 2021-07-02 |
Family
ID=76568164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110471927.3A Pending CN113057244A (en) | 2021-04-29 | 2021-04-29 | Preparation process of tablet candy with immunoregulation effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113057244A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115644299A (en) * | 2022-11-03 | 2023-01-31 | 甘肃长征药业集团有限公司 | Radix astragali tablet candy and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475589A (en) * | 2015-12-02 | 2016-04-13 | 青岛浩大海洋保健食品有限公司 | Sugar-free shark fin bone meal tablet candy for preventing tumors and improving immunity, and production technology thereof |
| CN106072635A (en) * | 2016-06-22 | 2016-11-09 | 运城学院 | A kind of preparation method of Radix Ginseng buccal tablet |
| CN107279420A (en) * | 2017-08-23 | 2017-10-24 | 李钦超 | A kind of pressed candy and preparation method thereof |
| CN112007106A (en) * | 2020-08-31 | 2020-12-01 | 山东省现代中药研究院有限公司 | Fermented composition for auxiliary prevention of COVID-19 and preparation method thereof |
| CN112021568A (en) * | 2020-08-31 | 2020-12-04 | 山东省现代中药研究院有限公司 | Medicinal and edible functional composition for assisting epidemic prevention of new coronavirus |
-
2021
- 2021-04-29 CN CN202110471927.3A patent/CN113057244A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105475589A (en) * | 2015-12-02 | 2016-04-13 | 青岛浩大海洋保健食品有限公司 | Sugar-free shark fin bone meal tablet candy for preventing tumors and improving immunity, and production technology thereof |
| CN106072635A (en) * | 2016-06-22 | 2016-11-09 | 运城学院 | A kind of preparation method of Radix Ginseng buccal tablet |
| CN107279420A (en) * | 2017-08-23 | 2017-10-24 | 李钦超 | A kind of pressed candy and preparation method thereof |
| CN112007106A (en) * | 2020-08-31 | 2020-12-01 | 山东省现代中药研究院有限公司 | Fermented composition for auxiliary prevention of COVID-19 and preparation method thereof |
| CN112021568A (en) * | 2020-08-31 | 2020-12-04 | 山东省现代中药研究院有限公司 | Medicinal and edible functional composition for assisting epidemic prevention of new coronavirus |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115644299A (en) * | 2022-11-03 | 2023-01-31 | 甘肃长征药业集团有限公司 | Radix astragali tablet candy and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101177665B (en) | Industrial method for culturing north winter worm summer herb with high-content of cordycepin | |
| US10835552B2 (en) | Method for preparing linseed polysaccharide having antiviral activity and immunological activity, and use of the linseed polysaccharide | |
| CN111533820A (en) | Notoginseng polysaccharide and its preparation method and use | |
| CN110882285A (en) | Efficient preparation method of active substances in phellinus igniarius | |
| CN113057244A (en) | Preparation process of tablet candy with immunoregulation effect | |
| KR101564487B1 (en) | Manufacturing method of small molecule Ginsenoside | |
| CN114591448A (en) | Phellinus igniarius sporophore mannogalactan and preparation and application thereof | |
| CN107712170A (en) | A kind of preparation method and applications of soluble dietary fiber | |
| CN103275237A (en) | Preparation method and application of eggplant branch polysaccharide | |
| CN114957497B (en) | Gentiana rigescens acidic polysaccharide and preparation method and application thereof | |
| CN113105567B (en) | Paecilomyces cicadae mannan and preparation and application thereof | |
| Cao et al. | Extraction of porphyran from Porphyra yezoensis for gel formulation preparation | |
| CN112794925B (en) | Amomum villosum polysaccharide and preparation method and application thereof | |
| CN1226308C (en) | Wolfberry fruit polysaccharide separating and purifying technology | |
| CN108359021B (en) | Method for rapidly preparing flaxseed polysaccharide with antiviral and immunoregulatory activities | |
| CN108530557B (en) | Laminarin extraction and purification process and application | |
| CN109234333B (en) | Method for preparing high-immunocompetence dendrobium officinale endophytic fungi polysaccharide through liquid fermentation | |
| LU502945B1 (en) | Efficient preparation method of active substances in sanghuangporus vaninii | |
| CN115651949B (en) | Bletilla mannan oligosaccharide and preparation method and application thereof | |
| CN114230682B (en) | Functional banana polysaccharide BPF2 and preparation and application thereof | |
| CN115141289B (en) | Acidic pseudo-ginseng polysaccharide and preparation method and application thereof | |
| CN114917246B (en) | Application of raspberry polysaccharide R2 in preparation of anti-tumor drugs and anti-inflammatory preparations | |
| CN114917245B (en) | Application of raspberry polysaccharide R1 in preparation of anti-tumor drugs and anti-inflammatory preparations | |
| CN115109168B (en) | Gentiana rigescens neutral polysaccharide and preparation method and application thereof | |
| CN116425901B (en) | Bitter bamboo shoot polysaccharide and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210702 |
|
| RJ01 | Rejection of invention patent application after publication |